![logo](/logos/NVNO.webp)
enVVeno Medical Corporation
NASDAQ:NVNO
5.75 (USD) • At close July 26, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | enVVeno Medical Corporation |
Symbool | NVNO |
Munteenheid | USD |
Prijs | 5.75 |
Beurswaarde | 76,647,500 |
Dividendpercentage | 0% |
52-weken bereik | 3.4 - 6.97 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Robert A. Berman |
Website | https://www.envveno.com |
An error occurred while fetching data.
Over enVVeno Medical Corporation
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency.
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)